DIRS.INFO The most relevant business & tech news

☆ British billionaire Joe Lewis fined $5 million by U.S. judge for insider trading
▼ + stars: | 2024-04-04 | by ( ) www.cnbc.com time to read: +3 min

British billionaire and former owner of the Tottenham Hotspur Football Club Joe Lewis arrives at federal court for his sentencing in an insider trading case on April 4, 2024, in New York City. U.S. District Judge Jessica Clarke in Manhattan sentenced Lewis, who pleaded guilty in January to one count of conspiracy and two counts of securities fraud. Lewis in January entered a plea deal with prosecutors agreeing to a $50 million fine of his Bahamas company, Broad Bay. Under the agreement, Lewis' fine will be included in the total. Lewis has since remained in the country, posting $300 million bail secured by his yacht and a private aircraft.

Persons: Tottenham Hotspur Football Club Joe Lewis, Lewis, Joe Lewis, Jessica Clarke, Mr, Mark Herr, Prosecutors, Boxer Capital, Patrick O'Connor, Bryan Waugh Organizations: Tottenham Hotspur Football Club, US, Office, Southern, of New York, Tavistock Group, Aviva, London's Tottenham Hotspur, Boxer, Forbes, Prosecutors, Mirati Therapeutics, Boxer Capital, Tango Therapeutics Locations: New York City, U.S, Manhattan, London's, Bahamas, Broad Bay, London, New York

☆ Personal pilot for billionaire Joe Lewis pleads guilty to insider trading scheme
▼ + stars: | 2024-02-26 | by ( Dan Mangan | ) www.cnbc.com time to read: +1 min

Damian Williams, U.S. Attorney for the Southern District of New York, speaks during a press conference in New York City, Sept. 22, 2023. A personal pilot for British billionaire investor Joe Lewis pleaded guilty Monday to securities fraud related to the same insider trading scheme that Lewis admitted guilt in a month ago, federal prosecutors in New York said. The pilot, Patrick O'Connor, on multiple occasions, received material, nonpublic information about companies from Lewis that O'Connor then used to trade in shares of those firms, prosecutors said. Lewis is the principal owner of the Tavistock Group, a private investment firm, and controlled one or more board of director seats at companies in which he shared nonpublic information with O'Connor that the pilot then traded on, prosecutors said. Lewis, through a family trust, formerly controlled a majority ownership stake in the English Premier League soccer team Tottenham Hotspur.

Persons: Damian Williams, Joe Lewis, Lewis, Patrick O'Connor, O'Connor, Mirati Organizations: Attorney, Southern, of, Tavistock Group, English Premier League soccer, Tottenham Hotspur, Mirati Therapeutics, Manhattan U.S, Attorney's Locations: U.S, of New York, New York City, New York

☆ British billionaire Joe Lewis pleads guilty to U.S. insider trading charges
▼ + stars: | 2024-01-24 | by ( ) www.cnbc.com time to read: +3 min

British billionaire Joe Lewis pleaded guilty to U.S. insider trading charges on Wednesday, and apologized to a judge for his conduct. Lewis, 86, pleaded guilty to one count of conspiracy to commit securities fraud and two counts of securities fraud, as part of an agreement with the U.S. Attorney's office in Manhattan. Addressing U.S. District Judge Jessica Clarke, Lewis said he knew at the time that what he was doing was wrong. Lewis was charged by federal prosecutors with 16 counts of securities fraud and three counts of conspiracy, for alleged crimes spanning from 2013 to 2021. While Lewis will not plead guilty to the other counts under the terms of his deal, Clarke said she may consider them for sentencing purposes.

Persons: Joe Lewis, David Zorno, Valerie Figueredo, Lewis, David Zornow, Jessica Clarke, Patrick O'Connor, Bryan Waugh, Clarke, Damian Williams Organizations: U.S, Tottenham Hotspur, Tavistock Group, Forbes, Aviva, Prosecutors, Mirati Therapeutics, BCTG, Tango Therapeutics, Manhattan U.S Locations: Manhattan, New York City, United States, New York , Florida, Georgia, Mirati

☆ Bristol Myers says it needs another year to hit target for new drugs
▼ + stars: | 2023-10-26 | by ( Michael Erman | ) www.reuters.com time to read: +2 min

Bristol Myers reported that it earned $4.1 billion, or $2 per share, in the third quarter, down from $4.3 billion, or $1.99 a share, a year earlier. Analysts, on average, had expected earnings per share of $1.76. It now expects earnings per share in the range of $7.50 to $7.65, up from its previous target of $7.35 to $7.65. Chief Operating Officer Chris Boerner is expected to become chief executive of Bristol Myers next month, replacing current CEO Giovanni Caforio. Earlier in October, BMS agreed to buy cancer drugmaker Mirati Therapeutics (MRTX.O) for up to $5.8 billion, in an attempt to diversify its oncology business.

Persons: David Elkins, Bristol Myers, Chris Boerner, Giovanni Caforio, Michael Erman, Sriparna Roy, Leslie Adler Organizations: Bristol Myers Squibb, BMS, Bristol, Therapeutics, Thomson Locations: The New Jersey

☆ Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
▼ + stars: | 2023-10-26 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company's popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers also reiterated its full-year revenue guidance of a low single-digit percentage decline. Bristol Myers said both older and new drug products helped offset the lower sales of Revlimid for the third quarter. Eliquis, which Bristol Myers shares with Pfizer , is among the first ten drugs selected to face price negotiations with the federal Medicare program. Bristol Myers will hold an earnings call with investors at 8 a.m. E.T.

Persons: Revlimid, Bristol Myers, –, Eliquis, FactSet, Opdualag Organizations: Bristol Myers Squibb, Bristol, LSEG, Pfizer, FactSet, Therapeutics Locations: Wednesday's

☆ Top Wall Street analysts favor these five dividend stocks during tumultuous times
▼ + stars: | 2023-10-22 | by ( Tipranks.Com Staff | ) www.cnbc.com time to read: +7 min

The company paid a dividend of $1.74 per share in late September, which included a quarterly base dividend of 50 cents per share and a variable dividend of $1.24. The acquisition, anticipated to close in January 2024, is expected to boost CIVI's free cash flow per share by 5% in 2024. In September, the company announced a quarterly dividend of 57 cents per share, payable on Nov. 1. (See Chesapeake Insider Trading Activity on TipRanks)EOG ResourcesLet's look at another energy company: EOG Resources (EOG). Based on this quarterly dividend, the annual dividend rate comes to $3.30 per share, bringing the dividend yield to 2.5%.

Persons: Paresh Dave, Wall, Civitas, Lloyd Byrne, CIVI, Byrne, TipRanks, Bristol Myers, BMY, Goldman Sachs, Chris Shibutani, Shibutani, Umang Choudhary, Choudhary, EOG, Nitin Kumar, Eagle, Kumar Organizations: Cisco Systems Inc, Civitas, Civitas Resources, Vencer Energy, Jefferies, Midland, Bristol, Bristol Myers Squibb, Mirati Therapeutics, Chesapeake Energy, Management, Chesapeake, EOG, Eagle Ford, TipRanks, Cisco Locations: San Jose , California, Denver, Midland, West Texas

☆ Risky biotech M&A therapy will heal more fractures
▼ + stars: | 2023-10-19 | by ( Jonathan Guilford | ) www.reuters.com time to read: +8 min

NEW YORK, Oct 19 (Reuters Breakingviews) - How can a suitor offering $1 billion see eye-to-eye with a seller asking for $2 billion? Such contingent value rights, or CVRs, are a way to get around the inherent uncertainty of an unproven drug. Its $74 billion takeover of Celgene in 2019 included a $6.4 billion payout dependent on a trio of drug approvals. There have been only 27 biotech market debuts this year, raising $2.2 billion, according to LSEG data. Given the nagging fissures in valuation perspectives, however, more dealmakers are apt to try this risky M&A therapy.

Persons: Schulman, Sidley, Bristol Myers, Myers, CVRs, Andrew Weisenfeld, IPOs, ”, Dan Lepanto, biopharma, Eli Lilly’s, Bristol Myers Squibb, Jeffrey Goldfarb, Sharon Lam, Streisand Neto Organizations: Reuters, Dow, Marion Laboratories, LyondellBasell Industries, Mirati Therapeutics, JPMorgan, Sanofi, Health Partners, Nasdaq Biotechnology, Reuters Graphics Reuters, Reuters Graphics, Leerink Partners, Therapeutics, Public, Bristol Myers, U.S . Food, Drug Administration, Thomson Locations: Celgene, Genzyme, U.S

☆ Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
▼ + stars: | 2023-10-09 | by ( Stuart Condie | ) www.wsj.com time to read: 1 min

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/bristol-myers-squibb-to-acquire-mirati-therapeutics-in-deal-worth-up-to-5-8-billion-7d83106

Persons: Dow Jones Organizations: bristol, myers, squibb

☆ Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
▼ + stars: | 2023-10-09 | by ( Michael Erman | ) www.reuters.com time to read: +3 min

REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsOct 8 (Reuters) - Bristol-Myers Squibb (BMY.N) on Sunday said it will acquire cancer drugmaker Mirati Therapeutics (MRTX.O) for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can help offset expected lost revenue from patent expirations later this decade. Bristol will pick up Mirati's portfolio drugs that target the genetic drivers of specific cancers including its lung cancer drug, Krazati, which was approved in December. The company said that it will buy Mirati for $58 per share in cash, or around $4.8 billion. Mirati has around $1.1 billion in cash on hand, so "we're paying essentially $3.7 billion enterprise value...we think with that we've gotten a very attractive deal," Lenkowsky said. Last year, Bristol acquired drug developer Turning Point Therapeutics for $4.1 billion in cash to help bolster its arsenal of cancer drugs.

Persons: Bristol Myers, Dado Ruvic, Adam Lenkowsky, Mirati, we've, Lenkowsky, Chris Boerner, Giovanni Caforio, Boerner, Lavanya Ahire, Lisa Shumaker, Diane Craft, Andrea Ricci, Michael Perry Organizations: Bristol, Bristol Myers Squibb, REUTERS, Myers Squibb, Therapeutics, U.S . Food, Drug Administration, Bristol Myers, Thomson Locations: Bristol, U.S, New York

☆ Stocks making the biggest moves premarket: Exxon Mobil, Lockheed Martin, Walt Disney and more
▼ + stars: | 2023-10-09 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

An Exxon gas station sign is seen on October 06, 2023 in the Brooklyn borough of New York City. The Wall Street firm said the software stock is at an attractive entry point after its recent pullback. Exxon Mobil , Chevron , Occidental Petroleum — Energy stocks popped as oil prices rallied following the Hamas attack on Israel over the weekend. Blue Owl Capital — Shares of the investment company dropped 2.6% after Oppenheimer downgraded Blue Owl Capital to perform from outperform. Lockheed Martin — The aerospace and defense company saw shares rise about 4.5% in premarket trading following the surprise attack on Israel by Palestinian militant group Hamas over the weekend.

Persons: Walt, Nelson Peltz's, Trian's, Trian, Saket Kalia, Oppenheimer, Bristol Myers, Tesla, Lockheed Martin, — CNBC's Brian Evans, Lisa Kailai Han, Fred Imbert, Hakyung Kim, Yun Li, Tanaya Macheel, Pia Singh Organizations: Exxon, Walt Disney —, Street Journal, Management, JPMorgan, Spotify Technology, Barclays, Oracle, ISI, Exxon Mobil, Occidental Petroleum — Energy, Chevron, Occidental, Owl, Mirati Therapeutics, Bristol, Bristol Myers Squibb, China Passenger Car Association, Lockheed, Hamas Locations: Brooklyn, New York City, Chevron, Israel, China, Palestinian

☆ Stocks making the biggest moves midday: General Dynamics, United Airlines, Spotify and more
▼ + stars: | 2023-10-09 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Spotify — Shares of the music streaming service company fell 2.5% after Redburn Atlantic downgraded the streaming giant to neutral from buy. Tesla — The automaker's stock fell 2.3% in Monday trading upon news that the company's year-over-year sales declined 10.9% in China last month, according to data from the China Passenger Car Association. Oil stocks — Energy stocks soared following the escalation of the Israel-Hamas conflict over the weekend. Airline stocks — On a broader level, airline names were down after several major airlines suspended service to Israel following this weekend's attacks. United Airlines slid 5.3%, while Delta Air Lines and American Airlines shed 4.5% and 5.3%, respectively.

Persons: Elizabeth, Saket Kalia, Bristol Myers, Tesla, Baird, — Datadog, Hess, Northrop Grumman, Yun Li, Tanaya Macheel, Sarah Min, Jesse Pound Organizations: General Dynamics Corp, Spotify, Atlantic, Amazon, Barclays, Therapeutics, Bristol, Bristol Myers Squibb, China Passenger Car Association, Motorola Solutions, Motorola, Bank of America, — Energy, Halliburton, CF Industries, Defense, L3Harris Technologies, General Dynamics, Airline, United Airlines, Delta Air Lines, American Airlines Locations: NASSCO, Norfolk , Virginia, China, Israel, Palestine

☆ Bristol-Myers Squibb to acquire Mirati in $5.8 billion deal
▼ + stars: | 2023-10-08 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsOct 8 (Reuters) - Bristol-Myers Squibb (BMY.N) on Sunday said it will acquire Mirati Therapeutics (MRTX.O) in a transaction that values the cancer drugmaker at up to $5.8 billion. The company said that it will buy Mirati for $58 per share in cash. Mirati stockholders will receive one non-tradeable contingent value right for each Mirati share held, potentially worth $12.00 per share in cash, representing an additional $1 billion of value opportunity, the company added. Bristol-Myers Squibb will finance the transaction with a combination of cash and debt, the company said in a statement. Last year, Bristol-Myers acquired drug developer Turning Point Therapeutics for $4.1 billion in cash to help bolster its arsenal of cancer drugs.

Persons: Bristol Myers, Dado Ruvic, Myers, Chris Boerner, Giovanni Caforio, Boerner, Lavanya Ahire, Lisa Shumaker, Diane Craft, Andrea Ricci Organizations: Bristol, Bristol Myers Squibb, REUTERS, Myers Squibb, Mirati Therapeutics, Bristol Myers, Therapeutics, Thomson Locations: Bristol, U.S, New York

NEW YORK, July 26 (Reuters) - British billionaire Joe Lewis has surrendered to U.S. authorities in Manhattan and is expected to appear in court later on Wednesday to face insider trading charges, a spokesperson for the U.S. Attorney's office in Manhattan said. Two of Lewis' pilots, Patrick O'Connor and Bryan Waugh, were also charged with insider trading securities fraud. Joe Lewis is a wealthy man," Damian Williams, the U.S. Attorney in Manhattan, said in a statement. Insider trading has long been a focus of Williams' office, dating to 2009 when a crackdown began under one of his predecessors, Preet Bharara. Separately on Wednesday, the U.S. Securities and Exchange Commission filed a civil insider trading case against Lewis, O'Connor, Waugh and Lewis' then-girlfriend Carolyn Carter.

Persons: Joe Lewis, Lewis, Patrick O'Connor, Bryan Waugh, David Zornow, O'Connor, Waugh, O'Connor texted, Mirati, Daniel Levy, Dylan Martinez, Damian Williams, Williams, Preet Bharara, Carolyn Carter, Carter, Gurbir Grewal, Luc Cohen, Jonathan Stempel, Chris Prentice, Chizu Nomiyama, Daniel Wallis Organizations: YORK, U.S, Tottenham Hotspur, Tottenham, Prosecutors, Mirati Therapeutics, Southampton Premier League, Reuters, Tavistock Group, Forbes, Attorney, U.S . Securities, Exchange Commission, SEC, Thomson Locations: British, U.S, Manhattan, United States, New York, Virginia

NEW YORK, July 25 (Reuters) - Joe Lewis, the British billionaire and owner of the Tottenham Hotspur soccer team, has been criminally charged in New York for orchestrating a "brazen" insider trading scheme. Joe Lewis is a wealthy man," U.S. Attorney Damian Williams said in a video on the X social media platform, formerly known as Twitter. Insider trading has long been a focus of Williams' office, dating to 2009 when a crackdown began under one of his predecessors, Preet Bharara. Prosecutors said that in some insider trading cases, Lewis lent money to recipients of his tips, including in Oct. 2019 when he wired $1 million to two pilots so they could buy more Mirati shares. Reporting by Jonathan Stempel and Luc Cohen in New York; Editing by Chris Reese and Lincoln Feast.

Persons: Joe Lewis, Lewis, Damian Williams, " Williams, Williams, Preet Bharara, Mirati, Boss, Marty, JPMorgan Chase, Jonathan Stempel, Luc Cohen, Chris Reese, Lincoln Organizations: YORK, Tottenham Hotspur, Prosecutors, U.S, Tavistock Group, Forbes, Therapeutics, Biosciences, Australian Agricultural, U.S . Securities, Exchange Commission, JPMorgan, Thomson Locations: New York, Tavistock, Bear Stearns

Companies Mirati Therapeutics Inc FollowNEW YORK, July 26 (Reuters) - The British billionaire Joe Lewis pleaded not guilty on Wednesday to orchestrating what prosecutors called a "brazen" insider trading scheme by passing tips about companies in which he invested to friends, private pilots and a former girlfriend. Two of Lewis' pilots, Patrick O'Connor and Bryan Waugh, also pleaded not guilty to related insider trading charges, after being accused of making millions of dollars in illegal profit from Lewis' tips. British billionaire and Tottenham Hotspur owner Joe Lewis exits the United States Courthouse in Manhattan, following his appearance on insider trading charges, in New York City, U.S., July 26, 2023. Insider trading has long been a focus of Williams' office, dating to 2009 when a crackdown began under one of his predecessors, Preet Bharara. Separately on Wednesday, the U.S. Securities and Exchange Commission filed a civil insider trading case against Lewis, O'Connor, Waugh and Lewis' former girlfriend Carolyn Carter.

Persons: Joe Lewis, Lewis, Valerie Figueredo, Nicolas Roos, Patrick O'Connor, Bryan Waugh, David Zornow, O'Connor, Waugh, O'Connor texted, Mirati, Amr Alfiky Mirati, Prosecutors, Damian Williams, Williams, Preet Bharara, Carolyn Carter, Carter, Gurbir Grewal, Luc Cohen, Jonathan Stempel, Jody Godoy, Chris Prentice, Chizu Nomiyama, Daniel Wallis Organizations: Mirati Therapeutics, Tottenham Hotspur, Aviva, Tavistock Group, Forbes, Tottenham, Prosecutors, United, REUTERS, U.S, Attorney, U.S . Securities, Exchange Commission, SEC, Thomson Locations: British, Manhattan, United States, New York City, U.S, New York, Virginia, South Korea

☆ British billionaire Joe Lewis to appear in U.S. court on insider trading charges
▼ + stars: | 2023-07-26 | by ( ) www.cnbc.com time to read: +2 min

Joe Lewis at a Tottenham vs. Arsenal soccer match in north London in 2011. British billionaire Joe Lewis has surrendered to U.S. authorities in Manhattan and is expected to appear in court later on Wednesday to face insider trading charges, a spokesperson for the U.S. Attorney's office in Manhattan said. Two of Lewis' pilots, Patrick O'Connor and Bryan Waugh, were also charged with insider trading securities fraud. They reaped millions of dollars in illegal profit from Lewis' tips, prosecutors said. After Mirati announced the positive results, its share price increased 16.7% in one day, and both pilots repaid Lewis for his loans.

Persons: Joe Lewis, Lewis, Patrick O'Connor, Bryan Waugh, David Zornow, O'Connor, Waugh, O'Connor texted, Mirati Organizations: Tottenham, Arsenal, U.S, Tottenham Hotspur, Prosecutors, Mirati Therapeutics Locations: London, U.S, Manhattan, United States

☆ Joe Lewis, Billionaire Owner of Tottenham Hotspur, Charged with Insider Trading
▼ + stars: | 2023-07-26 | by ( Michael J. De La Merced | More About Michael J. De La Merced | ) www.nytimes.com time to read: +1 min

Federal prosecutors charged Joseph C. Lewis, the British billionaire who owns the Tottenham Hotspur English soccer club, with insider trading on Tuesday, accusing him of illegally funneling nonpublic information to associates to trade on. In a 29-page indictment, prosecutors in Manhattan accused the 86-year-old financier of doling out tips to friends and associates, including his pilots, personal assistants and romantic partners from 2019 to 2021. “He used inside information as a way to compensate employees and shower gifts on friends and lovers,” Damian Williams, the United States Attorney for the Southern District of New York, said in a statement. “It’s cheating and against the law.”Prosecutors also accused Mr. Lewis of conspiring to hide a roughly 20 percent stake in Mirati Therapeutics, a pharmaceutical company, through a series of shell companies and false statements to the Securities and Exchange Commission.

Persons: Joseph C, Lewis, ” Damian Williams, “ It’s, ” Prosecutors Organizations: Tottenham Hotspur English, United States, Southern, of, ”, Mirati Therapeutics, Securities and Exchange Commission Locations: Manhattan, of New York

☆ Billionaire Joe Lewis has been charged with insider trading, with prosecutors saying he helped personal pilots, assistants, and romantic partners make 'millions'
▼ + stars: | 2023-07-26 | by ( Grace Dean | ) www.businessinsider.com time to read: +5 min

Tottenham Hotspur owner Joe Lewis has been charged by federal prosecutors with insider trading. The British billionaire passed information to his pilots, assistants, and romantic partners, an indictment says. In one case cited, Lewis is said to have lent his pilots $500,000 each to buy stock before insider information became public. British billionaire Joe Lewis has been charged by federal prosecutors with insider trading, with prosecutors saying that he passed information to personal pilots, assistants, romantic partners, and a friend he played poker with. According to the indictment, Lewis even gave his pilots $500,000 each in short-term loans so that they could buy stock before the news became public.

Persons: Joe Lewis, Lewis, Damian Williams, Williams, David M, Zornow, Mr, Mirati, couldn't Organizations: Tottenham Hotspur, Morning, Court, Southern, of, US, Bloomberg, Tavistock Group, English, Solid Biosciences, Australian Agricultural Company Locations: of New York, Bahamas, Argentina, Queensland, Tavistock, Mirati

☆ New Drugs Are Coming to Market at Sky-High Prices
▼ + stars: | 2023-03-09 | by ( Peter Loftus | ) www.wsj.com time to read: 1 min

A new Amgen Inc. lung-cancer treatment, Lumakras, carried a hefty price tag when it came out in 2021: $17,900 per patient monthly. Just over a year later, in December 2022, a second drug for the same type of cancer, Krazati from Mirati Therapeutics Inc., had an even higher price: $19,750 a month—a 10% premium.

☆ Stocks making the biggest moves midday: AMC Entertainment, Tesla, Micron, Under Armour and more
▼ + stars: | 2022-12-22 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Tesla — Shares fell more than 9% during Thursday trading. Analysts expected earnings of 70 cents a share on $7.29 billion in revenue. Under Armour — Shares fell more than 4% Thursday. TuSimple — Shares dropped more than 12% after TuSimple said it would cut 25% of its workforce, which would affect about 350 employees at the self-driving truck startup. Airline stocks — A slew of airline stocks fell Thursday amid news of hundreds of flight cancellations as a massive winter storm hit the U.S. American and United slumped 5.5% and 4%, respectively.

☆ Stocks making the biggest moves premarket: CarMax, Micron, Under Armour and others
▼ + stars: | 2022-12-22 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Check out the companies making headlines before the bell:CarMax (KMX) – The auto retailer's stock slumped 12.7% in the premarket after its quarterly profit and revenue fell well short of estimates. Micron Technology (MU) – Micron shares fell 2.9% in premarket trading after the chip maker reported a wider-than-expected quarterly loss and revenue that fell short of Wall Street forecasts. Tyson fell 1% in premarket action. Global Business Travel Group (GBTG) – The American Express spin-off was rated outperform in new coverage at Evercore ISI, which expects the business travel platform to benefit from its leading position in the industry and from a rebound in business travel recovery. Global Business Travel Group rose 1.6% in premarket trading.

☆ Stocks making the biggest moves in the premarket: Oracle, Boeing, Moderna and more
▼ + stars: | 2022-12-13 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Boeing (BA) – Boeing rose 2.2% in premarket action after United Airlines (UAL) announced a 200-jet order that includes 100 787 Dreamliners and 100 737 Max jets, with options for further purchases. Moderna (MRNA) – The drugmaker announced that its experimental melanoma vaccine combined with Merck (MRK) cancer treatment Keytruda cut the risk of skin cancer recurrence by 44% compared with a treatment of only Keytruda. First Solar (FSLR) – First Solar rose 1.1% in premarket trading following news that it will replace Fortune Brands Home & Security (FBHS) in the S&P 500. Mirati Therapeutics (MRTX) – Mirati Therapeutics surged 8.6% in premarket trading after the drugmaker's new lung cancer treatment adagrasib received Food and Drug Administration approval. Fiverr (FVR) – Fiverr added 1.1% in premarket trading after Citi initiated coverage of the stock with a "buy" rating.

[1/2] The Wall Street entrance to the New York Stock Exchange (NYSE) is seen in New York City, U.S., November 15, 2022. Future economic growth prospects were in focus on Tuesday following comments from financial titans pointing toward uncertain times ahead. The S&P banks index (.SPXBK) was down 2.6%, with Bank of America leading declines with a 5.6% drop. Fears about economic growth come amid a re-evaluation by traders of what path future interest rate hikes will take, following strong data on jobs and the services sector in recent days. "If economic growth continues to be better than what people are expecting, there are chances that the Fed would have to continue to be hawkish," said Rusty Vanneman, chief investment strategist at Orion Advisor Solutions.

☆ These are JPMorgan's top stock picks for December
▼ + stars: | 2022-12-05 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

JPMorgan has unveiled its top picks for December, as traders try to wrap up a tumultuous year on a strong note. JPMorgan's price target of $26 per share implies an upside of 12.9% from Friday's close. "The stock offers good value in the already discounted strip center sector, and we see its self-funded redevelopment program as driving NAV/FFO growth over time," said Nicholas Rosato, JPMorgan's head of North America equity research. "We like GWRE for its scale, focus on large Tier carriers, visible cloud market share gains and high liquidity of shares," Rosato said. Dollar Tree , TransUnion and Mirati Therapeutics remained among JPMorgan's top picks, along with Amazon, Public Storage, S & P Global and Allstate.

☆ Mirati attracts fresh takeover interest - Bloomberg News
▼ + stars: | 2022-11-22 | by ( ) www.reuters.com time to read: +1 min

Nov 22 (Reuters) - Mirati Therapeutics Inc (MRTX.O) is attracting fresh takeover interest from large pharmaceutical companies ahead of updates to its drug pipeline, Bloomberg News reported on Tuesday, citing people with knowledge of the matter. Larger drugmakers have been considering taking over the company, the report said, although there are currently no formal bids. Mirati has become a more attractive target for companies seeking to expand their cancer treatment offerings since larger rival Seagen Inc. (SGEN.O) opted to stay independent. The cancer drug developer has been weighing strategic options including a potential sale for some time, the report added. Reporting by Leroy Leo in Bengaluru; Editing by Krishna Chandra Eluri and Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.

Search resuls for: "Mirati"

25 mentions found